⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ARTV News
Artiva Biotherapeutics, Inc. Common Stock
Artiva Biotherapeutics Announces Positive Initial Safety and Translational Data Supporting Deep B-Cell Depletion with AlloNK® in Autoimmune Disease
globenewswire.com
ARTV
Artiva Biotherapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights
globenewswire.com
ARTV
Artiva Biotherapeutics to Host Virtual Event Discussing Initial Safety and Translational Data in up to 32 Patients with Autoimmune Disease Treated with AlloNK®
globenewswire.com
ARTV
Artiva Biotherapeutics to Participate in Upcoming Investor Conferences in November
globenewswire.com
ARTV
Artiva Biotherapeutics Announces Refractory Rheumatoid Arthritis as Lead Indication, Upcoming Data Releases, and Corporate Update
globenewswire.com
ARTV